Parse Biosciences
Facts
- HQ
- Seattle, Washington, U.S.
- Sectors
- Biotechnology Research
- Founded
- 2018
- Type
- Corporation Seattle business license
- Employees
- 149
- Registered name
- Parse Biosciences Inc Seattle business license
Washington Research Foundation Commits $1.7M to Renew UW–WSU Postdoctoral Entrepreneurship Collaboration
The Washington Research Foundation has committed $1.7 million over three years to support the UW CoMotion–WSU Postdoctoral Entrepreneurship Program, building on a prior $1.2 million grant in 2023. This funding supports postdoctoral researchers with mentorship and training to foster innovation, entrepreneurship, and commercialization across Washington's research institutions.
Seattle’s UW research, Amazon alumni and military adjacency fuel startups building high-stakes, regulation-ready AI for biotech, finance and government
A Seattle high-school intern argues that strict school AI rules illuminated why AI must be disciplined in high-stakes domains, and describes how Seattle's research institutions (notably UW and the David Baker ecosystem), Amazon alumni, and military adjacency produce founders building accountable, regulation-ready AI for biotech, finance, and government.
Qiagen to Acquire Seattle’s Parse Biosciences for $225 Million in Cash Deal Closing December 2023
Seattle's Parse Biosciences, a single-cell RNA sequencing company founded in 2018, is being acquired by Netherlands-based Qiagen in a $225 million cash deal expected to close in December. Parse, which serves 3,000 customers globally and raised over $50 million in funding, will continue operating from its Seattle headquarters as a Qiagen subsidiary.
GeekWire returns in person for 2022 Awards at Showbox SoDo, honoring 60+ finalists across 15 categories with 16,000+ votes
GeekWire held its first in-person GeekWire Awards in three years at Showbox SoDo in Seattle, honoring 60+ finalists across 15 categories with over 16,000 community votes and appearances by local tech leaders and entertainers.
Parse Biosciences raises $41.5M to scale Evercode single-cell RNA sequencing kits that profile up to 1M cells
Parse Biosciences, a Seattle startup co-founded by CEO Alex Rosenberg and CTO Charles Roco, raised $41.5 million to expand its single-cell RNA sequencing kits and software, which scale to profile up to one million cells using standard lab equipment. The company, launched from University of Washington research, now has more than 300 customers and emphasizes ease of use versus competitors requiring specialized hardware.
Creative Destruction Lab to launch nine-month, equity-free Seattle accelerator with Microsoft and UW for 20–25 computational health startups this November
Creative Destruction Lab (CDL) is launching a Seattle hub this November at the University of Washington to run a nine-month, equity-free accelerator for 20–25 computational health startups in partnership with Microsoft and UW’s business, engineering, and computer science schools; UW students can shadow the program. The program is funded by founding members, enforces objective milestones with the possibility of booting nonperforming companies, and stems from UW’s Innovation Roundtable efforts led by Emer Dooley and others.
Parse Biosciences raises $7M led by Bioeconomy Capital to scale single-cell RNA-seq tech; total funding $9M
Parse Biosciences (formerly Split Biosciences) raised $7 million to grow its single-cell RNA-seq 'Whole Transcriptome Kit' that profiles up to 100,000 cells across 48 samples; the 16-person startup spun out of UW in 2018 and has 40+ labs using its kit.
People
-
Alex Rosenberg Founder, Cofounder and CEO
-
Charles Roco Founder, Co-founder and CTO
